ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

KRYS Krystal Biotech Inc

177.78
-4.94 (-2.70%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 492,509
Bid Price 169.40
Ask Price 177.00
News -
Day High 181.25

Low
93.95

52 Week Range

High
191.78

Day Low 174.29
Company Name Stock Ticker Symbol Market Type
Krystal Biotech Inc KRYS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-4.94 -2.70% 177.78 18:48:46
Open Price Low Price High Price Close Price Prev Close
180.21 174.29 181.25 177.78 182.72
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
13,851 492,509 $ 178.29 $ 87,808,794 - 93.95 - 191.78
Last Trade Time Type Quantity Stock Price Currency
16:56:29 1 $ 172.30 USD

Krystal Biotech Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
5.03B 28.29M - 50.7M 10.93M 0.39 460.33
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Krystal Biotech News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No KRYS Message Board. Create One! See More Posts on KRYS Message Board See More Message Board Posts

Historical KRYS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week164.50191.78161.63178.04707,14313.288.07%
1 Month164.37191.78154.50171.66334,81513.418.16%
3 Months171.10191.78144.0001168.32292,5106.683.90%
6 Months116.25191.78107.50151.43347,67361.5352.93%
1 Year130.32191.7893.95134.79319,91747.4636.42%
3 Years65.07191.7838.856399.41252,539112.71173.21%
5 Years30.61191.7822.0285.05214,939147.17480.79%

Krystal Biotech Description

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future.

Your Recent History

Delayed Upgrade Clock